SAVERONE 2014 LTD -ADR (SVRE)

US80516T1051 - ADR

1.58  +0.61 (+63.22%)

Premarket: 1.063 -0.52 (-32.72%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SVRE. SVRE was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. SVRE may be in some trouble as it scores bad on both profitability and health. SVRE is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SVRE has reported negative net income.
SVRE had a negative operating cash flow in the past year.
SVRE had negative earnings in each of the past 5 years.
In the past 5 years SVRE always reported negative operating cash flow.

1.2 Ratios

SVRE has a Return On Assets of -146.86%. This is amonst the worse of the industry: SVRE underperforms 95.20% of its industry peers.
The Return On Equity of SVRE (-336.37%) is worse than 93.60% of its industry peers.
Industry RankSector Rank
ROA -146.86%
ROE -336.37%
ROIC N/A
ROA(3y)-113.03%
ROA(5y)-427.84%
ROE(3y)-211.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 21.41%, SVRE is not doing good in the industry: 65.60% of the companies in the same industry are doing better.
SVRE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for SVRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.63%
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

SVRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SVRE has more shares outstanding
SVRE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SVRE is higher compared to a year ago.

2.2 Solvency

SVRE has an Altman-Z score of -12.51. This is a bad value and indicates that SVRE is not financially healthy and even has some risk of bankruptcy.
SVRE's Altman-Z score of -12.51 is on the low side compared to the rest of the industry. SVRE is outperformed by 95.20% of its industry peers.
SVRE has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
SVRE has a worse Debt to Equity ratio (0.49) than 74.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z -12.51
ROIC/WACCN/A
WACC8.07%

2.3 Liquidity

SVRE has a Current Ratio of 1.81. This is a normal value and indicates that SVRE is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.81, SVRE is not doing good in the industry: 68.00% of the companies in the same industry are doing better.
SVRE has a Quick Ratio of 1.28. This is a normal value and indicates that SVRE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.28, SVRE is doing worse than 68.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.28

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.35% over the past year.
The Revenue for SVRE has decreased by -24.41% in the past year. This is quite bad
The Revenue has been growing by 104.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)43.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.75%
Revenue 1Y (TTM)-24.41%
Revenue growth 3Y104.94%
Revenue growth 5YN/A
Sales Q2Q%-67.25%

3.2 Future

Based on estimates for the next years, SVRE will show a very strong growth in Earnings Per Share. The EPS will grow by 36.89% on average per year.
Based on estimates for the next years, SVRE will show a very strong growth in Revenue. The Revenue will grow by 88.54% on average per year.
EPS Next Y66.38%
EPS Next 2Y36.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-31.97%
Revenue Next 2Y88.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SVRE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SVRE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as SVRE's earnings are expected to grow with 36.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.89%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SVRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAVERONE 2014 LTD -ADR

NASDAQ:SVRE (12/24/2024, 7:39:51 PM)

Premarket: 1.063 -0.52 (-32.72%)

1.58

+0.61 (+63.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)09-20 2022-09-20/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change2.83%
Ins Owners1.73%
Ins Owner ChangeN/A
Market Cap3.97M
Analysts82.86
Price Target0.12 (-92.41%)
Short Float %0.07%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2531.11%
PT rev (3m)510.31%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-693.38%
EPS NY rev (3m)-1324.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-74.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.43
P/FCF N/A
P/OCF N/A
P/B 1.51
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-5.72
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-3.62
FCFYN/A
OCF(TTM)-3.62
OCFYN/A
SpS0.19
BVpS1.04
TBVpS1.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -146.86%
ROE -336.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.41%
FCFM N/A
ROA(3y)-113.03%
ROA(5y)-427.84%
ROE(3y)-211.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.63%
GM growth 5YN/A
F-Score1
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.16%
Cap/Sales 3.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.81
Quick Ratio 1.28
Altman-Z -12.51
F-Score1
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)22.69%
Cap/Depr(5y)54.23%
Cap/Sales(3y)13.97%
Cap/Sales(5y)23.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.75%
EPS Next Y66.38%
EPS Next 2Y36.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.41%
Revenue growth 3Y104.94%
Revenue growth 5YN/A
Sales Q2Q%-67.25%
Revenue Next Year-31.97%
Revenue Next 2Y88.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.83%
OCF growth 3YN/A
OCF growth 5YN/A